36C26326Q0051.pdf

PAGE 1 OF 45 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

11/12/2025

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

N/A

36C26326Q0051

Joshua Imdacha 3193397017 12-12-2025 4pm CST

36C263

DEPARTMENT OF VETERANS AFFAIRS

NETWORK CONTRACTING OFFICE 23

1303 5TH STREET, SUITE 300

CORALVILLE IA 52241

X

621991

$40 Million

N/A

X

DEPARTMENT OF VETERANS AFFAIRS

Sioux Falls VA Health Care System 2501 W 22nd Street

SIOUX FALLS SD 57105

DEPARTMENT OF VETERANS AFFAIRS

NETWORK CONTRACTING OFFICE 23

1303 5TH STREET, SUITE 300

CORALVILLE IA 52241

DEPARTMENT OF VETERANS AFFAIRS

FMS-VA-2(101)

FINANCIAL SERVICES CENTER

PO BOX 149971

AUSTIN TX 78714-9971

X

See CONTINUATION Page

NCO 23 has a requirement for blood, blood products, and necessary testing IDIQ for the Sioux Falls SD VA Healthcare System.

See sections B.2-B.3 for details FAR 13.5 procedures LPTA Evaluation see provision 52.212-2

FOR CONSIDERATION ALL QUESTIONS MUST BE RECEIVED 72 HOURS

BEFORE DATE STIPULATED IN BLOCK 8 OF THE SF1449 FORM.

EMAIL ALL QUESTIONS AND RESPONSES TO JOSHUA.IMDACHA@VA.GOV

SIGN SF1449 AND RETURN ALL PAGES WITH OFFER SUBMISSION

ALL RESPONSES MUST BE SUBMITTED ELECTRONICALLY VIA EMAIL TO

JOSHUA.IMDACHA@VA.GOV

See CONTINUATION Page N/A

X X

X 1

Joshua Imdacha Contracting Officer

36C26326Q0051

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 STATEMENT OF WORK

B.3 PRICE/COST SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (DEVIATION AUG 2025)

C.2 52.216-18 ORDERING (AUG 2020)

C.3 52.216-19 ORDER LIMITATIONS (OCT 1995)

C.4 52.216-22 INDEFINITE QUANTITY (DEVIATION NOV 2025)

C.5 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR 1984) 33

C.6 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.7 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022)

C.8 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)

C.9 VAAR 852.222-71 COMPLIANCE WITH EXECUTIVE ORDER 13899

(DEVIATION)(APR 2025)

C.10 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV

2018)

C.11 VAAR 852.237-70 INDEMNIFICATION AND MEDICAL LIABILITY INSURANCE

(OCT 2019)

C.12 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)

C.13 VAAR 852.246-71 REJECTED GOODS (OCT 2018)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

D.1 36C26326Q0051 Supply Line Item Template

SECTION E - SOLICITATION PROVISIONS

E.1 52.212-1 Instructions to Offerors—Commercial Products and Commercial Services

(DEVIATION AUG 2025)

E.2 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.3 52.216-1 TYPE OF CONTRACT (APR 1984)

E.4 52.216-27 SINGLE OR MULTIPLE AWARDS (OCT 1995)

E.5 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.6 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.7 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION

(OCT 2018)

E.8 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.9 VAAR 852.239-75 INFORMATION AND COMMUNICATION TECHNOLOGY

ACCESSIBILITY NOTICE (FEB 2023)

E.10 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (DEVIATION AUG 2025)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C263

DEPARTMENT OF VETERANS AFFAIRS

NETWORK CONTRACTING OFFICE 23

1303 5TH STREET, SUITE 300

CORALVILLE IA 52241

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [x] monthly

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

https://www.tungsten-network.com

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

B.2 STATEMENT OF WORK

SPECIFICATIONS/STATEMENT OF WORK

Blood Products

The cost of all testing for infectious diseases and tests that are required by state or federal agencies [ Food and Drug Administration (FDA), American Association of Blood Banks (AABB), Code of Federal Regulations (CFR), and College of American Pathologists (CAP) shall be included in the offered prices.

No additional fees will be paid for blood testing. Contractor may be required to update assay methodologies, procedures, and/or otherwise provide new testing when such changes are mandated by the FDA (the "FDA-Mandated Changes"). If FDA-Mandated Changes are required during the contract, the Contractor will give prior notice to the Contracting Officer of anticipated change and any resulting change to cost of products or services. Contractor shall be permitted to seek a modification to cover the additional costs incurred by Contractor to provide the services and products required by FDA-Mandated Changes. If Contractor is not permitted to modify the contract to cover the cost of FDA-Mandated Changes, Contractor shall be permitted to stop offering the product impacted by FDA-Mandated Changes under this contract."

1. Blood will be typed and labeled for ABO and Rh antigens in accordance with methods recommended in the current edition of Standards for Blood Banks and Transfusion Services and the Technical Manual of the American Association of Blood Banks. A sample of blood from each donation will be tested for infectious diseases and all testing shall comply with AABB standards and , 21 CFR Parts 606,607,610,630,640,660 governing blood products. Products must be non-reactive for infectious disease markers prior to shipment, except with the express written authorization of the Veterans Administration (VA) Blood Bank Medical Director or his/her designee.

a. All blood is to be collected by the closed system under aseptic conditions and shall be processed in appropriate solutions and the container so labeled. The label shall also bear the expiration date of the contents.

b. All blood supplied will be grossly free of hemolysis, excessive chyle, and clots.

2. Contractor must maintain registration and/or licensure with the FDA, Department of Health and Human Services pursuant to Section 5l0 of the Federal Food, Drug and Cosmetic Act as amended, 2l USC Section 260. Contractor must also maintain U.S. License as issued by the Director, Bureau of Biologics, FDA under section 35l of the Public Health Act, as amended, 42 USC Section 262, as a source to supply whole blood. Copies of these will be provided to the Contracting Officer prior to award.

3. Contractor must provide the VA with l00% "volunteer donor" blood in accordance with FDA rules and regulations effective May l5, l978 or later revisions. Definition of a "volunteer donor" - A volunteer donor is a person who does not receive monetary payment for blood donation. Benefits, such as monetary time off from work, membership in blood assurance programs and cancellation on non-replacement fees that are not readily convertible to cash, do not constitute monetary payment."

4. Donor Requirements: Contractor must maintain readily available blood donor lists including names and addresses. Such lists should indicate whether, and on what date, blood of a particular donor was furnished to VA under this contract. Donor selection must be in accordance with criteria established by the FDA and/or the AABB.

5. Blood from VA patients may require typing, antibody detection, direct antiglobulin test (DAT) testing and cross matches. Cross matches may be on a STAT basis and require blood delivered to the VA within 3 hours of receipt of the blood sample, however, in the instance of patients with blood samples that require extensive review of antibodies to source a usable blood match (such as previous transfusion patients) it may be necessary to send the sample to an external lab for further review. In such instances, Contractor will communicate this to authorized VA lab personnel and the deadline shall be extended to 24 hours. The VA will be responsible for delivering samples to the contractor for the required testing.

6. Ordering/Shipping Requirements:

a. Non-emergency delivery schedules may be altered by contractor during holiday weeks (normal business hours are 7:00am to 3:30pm CST M-F). VA shall be informed in advance of any delivery schedule changes. Contractor must take telephone blood orders twenty-four (24) hours each day. The VA will pick up the orders. The VA will set up the pick-up schedule in coordination with vendor.

b. Oral orders for the delivery of requirements for the Blood Bank will be placed by authorized Blood Bank/Laboratory personnel on an "as needed" basis by calling vendor at (605) 333- 7081. The blood shall be available for pick-up as specified within twenty-four (24) hours following request, therefore. Emergency requirements are to be available for pickup by station personnel within 60 minutes of request.

c. All blood products picked up by VA under this contract shall be properly packed and insulated in such a way as to insure that appropriate temperature for the products is maintained during a normal automobile trip between contractor's place of business and VA Medical Center.

Shipping containers are supplied by the contractor.

d. Blood products shall be supplied as fresh as possible to minimize losses due to outdating. Red blood cells shall be returned to the offeror's facility for credit when the units are within 7 calendar days of expiration date.

e. Blood shall be shipped in clean Office of Biologics approved containers in accordance with all Federal and State Department of Transportation (DOT) requirements for the transportation of human blood and blood products. Red blood cells shall be transported in a manner to maintain a temperature of l-l0 degree C. Pooled cryoprecipitate, pooled platelets and individual platelets shall be transported at 20-24 degrees C. Fresh frozen plasma and individual units of cryoprecipitate shall be transported in a manner to maintain them frozen. Products received which do not meet these criteria shall be rejected and returned for full credit. Units of fresh frozen plasma which are received with broken bags shall be rejected and returned for full credit. Each shipment shall be accompanied by an itemized invoice including product description, ABO/Rh, unit number and expiration date.

7. Blood/Component Returns: VA shall be given full credit for any blood/components rejected and returned if it is mutually determined they are unsuitable for transfusion. Credit as indicated in Cost Schedule shall be given for all units rejected and units returned for credit that meet described expiration dates. Red blood cells returned at least 7 calendar days prior to expiration date if the following conditions are met:

a. The original blood/component label must not be obliterated or defaced with any non-removable markings or stickers.

b. At least two (2) segments for further test must remain attached to the original container of red blood cells.

c. The original tamperproof seal must not have been broken.

d. There must be recorded evidence of continuous storage at the proper temperature.

CFR 606.l60 requires documentation of continuous storage of blood/components. The recorded evidence must be validated by authorized personnel's signature.

Fresh frozen plasma shall be returned for credit when units are within two months of expiration date.

a. The original blood/component label must not be obliterated or defaced with any non-removable markings or stickers

b. The original tamperproof seal must not have been broken.

c. There must be recorded evidence of continuous storage at the proper temperature.

CFR 606.l60 requires documentation of continuous storage of blood/components.

The recorded evidence must be validated by authorized personnel's signature.

8. Records of Adverse Reactions: In accordance with CFR 21:606.170, VA agrees to maintain records of any suspected adverse reactions to blood/components supplied by the contractor by a recipient of the blood/component. If VA determines that the blood/component caused a serious adverse reaction, a written report shall be forwarded to the contractor within one calendar week (7 calendar days) of the reaction. A serious reaction is defined as being life-threatening, permanently disabling, or fatal.

Furthermore, VA agrees to report all cases of post-transfusion hepatitis, transfusion-associated Human Immunodeficiency Virus (HIV), and transfusion-associated fatalities to the contractor Medical Director where such cases are due to blood/components supplied by the contractor. Reports of transfusion-associated fatalities shall be made by telephone as soon as possible following the occurrence, and in no case more than 24 hours following the fatality. Other reports shall be made by telephone or letter within one calendar week (7 calendar days) after VA's notice of such post-transfusion illness.

9. Blood shall be furnished labeled as to A, B, O, and Rh type. Type A Rh negative and O Rh negative must have been drawn from donor, not more than 42 calendar days (based upon FDA guideline of a 42-day window for acceptable blood freshness) before date that purchase order is issued, except in instances where the 5 calendar day limit is required for medical necessity. Types such as AB Rh positive, B Rh negative, and AB Rh negative shall be supplied as fresh as possible, but not over 42 calendar days old.

These time limits may be adjusted, if a system for exchange on credit is provided which minimizes or precludes losses due to outdating. All units shall be in accordance with International Society of Blood Transfusion (ISBT) labeling.

10. Cryoprecipitate and platelets shall be pooled prior to shipment. No individual units shall be accepted unless specifically requested.

11. Contractor shall be paid, upon submission of monthly statement, in arrears, for all blood products furnished during the previous month, less any applicable credits.

12. Tests and products required with annual estimate:

TEST NAME CPT ESTIMATED

ANNUAL

VOLUME

Red blood cells P9016 450

Platelet concentrate P9019 120

Cryoprecipitate or platelet pooling 86965 5

Single donor plasma, fresh, frozen P9017 75

Cryoprecipitate P9012 24

Compatibility test (crossmatch) 86920 40

Antibody identification 86870 50

Antigen typing 86902 50

Autologous donation processing 86890 10

Direct antiglobulin test (DAT) 86880 40

Pooling charge 86965 30

Irradiation charge 86945 10

Rh 86901 40

ABO 86900 40

Antibody screen 86850 30

Genotyping 0180U 10

Phenotyping 86906 10

13. Contractor shall follow AABB, FDA, CAP and Joint Commission guidelines when performing tests listed below. The following tests should be completed within the designated turn-around-times on a 24/7 hour basis. In the event that the results of one test prompts the necessity of the performance of another test on this list, the turn-around time shall be considered satisfied if the Contractor provides all tests within the sum of the turn-around times below for all tests performed. Should the Contractor not be able to meet the required turn-around time below for any particular patient due to unforeseen circumstances related to the need for a sample to be subjected to extensive additional testing, the Contractor shall notify the authorized lab personnel who shall have the authority to determine whether to agree to a different turn-around time based on the facts and circumstances or cancel the order.

TEST NAME REQUIRED TURN-AROUND-TIME

(from time of receipt to completion of the test)

Compatibility test (crossmatch) 2 hours Antibody identification 2 hours Antigen typing 2 hours Direct antiglobulin test (DAT) 4 hours Rh 1 hours ABO 1 hours Antibody screen 1 hours Type and screen 1 hours Type and crossmatch 2 hours

Products must be labeled with ISBT 128 barcode labels.

14. Draw and preparation of blood donated by relatives, friends, and members of service organizations, for the specific use of the Department of Veterans Affairs patients shall be made available. The contractor shall cooperate in scheduling and accepting these donors.

15. CONTRACTOR RESPONSIBILITIES The contractor shall obtain all necessary licenses and/or permits required to perform this work. He/she shall take all reasonable precautions necessary to protect persons and property from injury or damage during the performance of this contract. He/she shall be responsible for any injury to himself/herself, his/her employees, as well as for any damage to personal or public property that occurs during the performance of this contract that is caused by his/her employee's fault or negligence, and shall maintain personal liability and property damage insurance having coverage for a limit as required by the laws of the State of South Dakota. Further, it is agreed that to the extent applicable to a Federal Employee’s actions, the Federal Tort Claims Act describes VA liability.”

16. INSURANCE REQUIREMENTS: In accordance with VAAR 852.237-7 Indemnification and Medical Liability Insurance the following minimum liability insurance coverage levels shall apply to this contract:

General Liability of not less than: $1,000,000.00 per occurrence.

The Contractor must present to the Contracting Officer, prior to award, evidence of general liability insurance without any exclusionary clauses that would void the general liability coverage.

17. ORDERING PROCEDURES:

Delivery orders will be placed by telephone or fax, on an as needed basis, by VA Medical Center (VAMC) Laboratory personnel twenty-four hours a day seven days per week. Names of Lab personnel authorized to place, accept, or reject orders shall be provided to the Contractor upon request. In accordance with the Invoices Procedures listed on page 3 the contractor shall submit invoices on a monthly basis listing all orders placed over the course of the month.

Lab personnel authorized to place, accept or reject orders: The names of the authorized personnel allowed to place orders will be named after award is made. The titles will be following: Medical Laboratory Technologist, Medical Laboratory Technicians.

From time to time, Contractor may experience shortages of one or more products. Contractor will make every effort to secure required products but may need to offer alternative products, possibly from external vetted third-party vendors (Contractor can provide list of said vendors for Contract Officer's review and approval), based upon product availability and the clinical needs of the SFVAMC. Contractor will use best efforts to seek prior approval from the Contract Officer to provide non-conforming products;

provided, however, that in the event of an emergent request from the authorized lab personnel from the SFVAMC requesting alternative products in lieu of those that are unavailable, the Contractor may provide a non-conforming products so long as the difference in the cost of the required products and the non-conforming alternative products does not exceed $500 per emergent request. Contractor will immediately send written notice of this authorized substitution to the COR and the Contract Officer.

18. RESULTING PROCEDURES:

Contractor must deliver results in a standardized, legible manner in which there would be no question for interpretation. (See attachment for example of standardization of resulting.) Each report shall at a minimum indicate the following information:

(a) Patient’s full name and Social Security number

(b) Physician’s name (if supplied)

(c) VA Medical Center name

(d) Patient’s location, e.g. clinic, ward (if supplied)

(e) Test ordered

(f) Date/time of specimen collection (when available)

(g) Date/time specimen received in Reference Lab

(h) Date test completed

(i) Test result

(j) Name of testing laboratory (contractor and/or subcontractor)

(k) Testing laboratory specimen number

(l) Type of specimen

(m) Comments related to the test provided by the submitting lab

(n) Information that may indicate a questionable validity of test results

(o) Unsatisfactory specimen shall be reported with reason as to its unsuitability for testing

Quality Control To ensure proper handling and test performance, the contractor shall provide the following updated information upon request during the life of the contract:

(a) Annual summary.

(b) Proficiency testing data.

(c) The contractor(s) facilities, methodologies (defined as the principal of the method and references), and quality control procedures may be examined by representatives of the VA at any time during the life of the contract.

(d) Contractor agrees to maintain the minimum acceptable service, reporting systems and quality controls as specified herein. Immediate (within 24 hours) notification must be given to VA upon adverse action by a regulatory agency.

Testing Changes The Contractor shall advise the VA of any changes in assay methodology, procedures, and any new tests introduced.

In the event the contractor changes the assay procedures or a critically important component of an assay the contractor shall notify the VA Contracting Office and the VA Laboratory Director prior to the intended change.

They shall provide documentation that the quality and efficacy of the test will remain unchanged or be improved.

Changes in the assay material, testing procedures or methodology that have not been reviewed and pre-approved by VA Laboratory Director and mutually agreed upon in writing between the contractor and the VA Contracting Officer, may be sufficient cause for the VA to use an alternate contractor for that specific test for the duration of the contract. Notwithstanding the foregoing, as outlined above Contractor may be required to update assay methodologies, procedures and/or provide new testing pursuant to FDA-Mandated Changes. Upon receipt of notice of anticipated FDA-Mandated Changes, Contractor shall notify Contract Officer of said changes and Contractor shall be permitted to seek a modification to cover the additional costs incurred by Contractor to provide the services and products required by FDA-Mandated Changes. If Contractor is not permitted to modify the contract to cover the cost of FDA-Mandated Changes, Contractor shall be permitted to stop offering the product impacted by the FDA-Mandated Change under this contract.

Planned Ordering periods:

• Base Period - 2/1/2026-9/30/2026 (8 months)

• Period 1 -10/01/2026-9/30/2027 (12 months)

• Period 2 -10/01/2027-9/30/2028 (12 months)

• Period 3 -10/01/2028-9/30/2029 (12 months)

• Period 4 -10/01/2029-9/30/2030 (12 months)

• Period 5 -10/01/2030-1/31/2031 (4 months)

B.3 PRICE/COST SCHEDULE

The Department of Veterans Affairs has set the maximum cost limitation for this IDIQ at $1,000,000.00 for the lifetime of this contract.

The guaranteed minimum value of this contract is set at $30,000.00.

Task orders will be placed at the beginning of each ordering period by the contracting officer in accordance with 52.216-18,52.216-19,52.216-22.

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES

ESTIMATED

QUANTITY UNIT UNIT PRICE AMOUNT

300.00 EA __________________ __________________

Red blood cells

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): P9016

LOCAL STOCK NUMBER: P9016

80.00 EA __________________ __________________

Platelet concentrate

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): P9019

LOCAL STOCK NUMBER: P9019

4.00 EA __________________ __________________

Cryoprecipitate or platelet pooling

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86965

LOCAL STOCK NUMBER: 86965

50.00 EA __________________ __________________

Single donor plasma, fresh, frozen

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): P9017

LOCAL STOCK NUMBER: P9017

16.00 EA __________________ __________________

Cryoprecipitate

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): P9012

LOCAL STOCK NUMBER: P9012

27.00 EA __________________ __________________

Compatibility test (crossmatch)

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86920

LOCAL STOCK NUMBER: 86920

34.00 EA __________________ __________________

Antibody identification

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86870

LOCAL STOCK NUMBER: 86870

34.00 EA __________________ __________________

Antigen typing

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86902

LOCAL STOCK NUMBER: 86902

7.00 EA __________________ __________________

Autologous donation processing

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86890

LOCAL STOCK NUMBER: 86890

Direct antiglobulin test (DAT)

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86880

LOCAL STOCK NUMBER: 86880

20.00 EA __________________ __________________

Pooling charge

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Irradiation charge

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86945

LOCAL STOCK NUMBER: 86945

Rh

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86901

LOCAL STOCK NUMBER: 86901

ABO

Contract Period: Base POP Begin: 02-01-2026

POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86900

LOCAL STOCK NUMBER: 86900

20.00 EA __________________ __________________

Antibody screen

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86850

LOCAL STOCK NUMBER: 86850

Genotyping

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 0180U

LOCAL STOCK NUMBER: 0180U

Phenotyping

Contract Period: Base POP Begin: 02-01-2026 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 86906

LOCAL STOCK NUMBER: 86906

450.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

120.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

5.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

75.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

24.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

40.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

10.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

30.00 EA __________________ __________________

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Irradiation charge Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 1 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028

PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Phenotyping Contract Period: Ordering Period 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029

PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 3 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Cryoprecipitate Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030

PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 4 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

150.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks

2.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

25.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

8.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

14.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

17.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

17.00 EA __________________ __________________

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Direct antiglobulin test (DAT) Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031 PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

Contract Period: Ordering Period 5 POP Begin: 10-01-2030 POP End: 01-31-2031

PRINCIPAL NAICS CODE: 621991 - Blood and Organ Banks PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

GRAND TOTAL __________________

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (DEVIATION AUG 2025)

(a) Definitions. The clause at Federal Acquisition Regulation (FAR) 52.202-1, Definitions, is incorporated by reference.

(b) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered; and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(c) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(d) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.

(e) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal, or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause FAR 52.233-1, Disputes, which is incorporated in this contract by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence. Examples of occurrences include acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. When an excusable delay occurs, the Contractor shall—

(1) Notify the Contracting Officer in writing as soon as possible;

(2) Remedy the delay as quickly as possible; and

(3) Notify the Contracting Officer when the occurrence is over.

(g) Invoice. The Government will handle invoices according to the Prompt Payment Act (31 U.S.C. 3903) and 5 CFR part 1315. The Contractor shall submit invoices to the address designated in the contract to receive invoices. An invoice must include the information required by 5 CFR part 1315.9(b).

(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees, and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark, or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.

(i) Payment—

(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery…